跳至主要内容
临床试验/ISRCTN99513870
ISRCTN99513870已完成不适用

nited Kingdom randomised trial for the management of screen-detected ductal carcinoma in situ (DCIS) of the breast

Cancer Research UK (CRUK) (UK)0 个研究点目标入组 1,000 人开始时间: 2001年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Unilateral or bilateral DCIS which is cosmetically suited to breast conservation, which has been detected as a result of attendance at a screening centre, which is without evidence of invasion, and which has been completely excised as determined by free margins on histological examination
  • 2. Patients with similarly defined DCIS lesions, in whom the diagnosis of DCIS has been made as a result of mammograms taken following referral to a diagnostic clinic
  • 3. Patients with Paget's disease of the nipple, lobular carcinoma in situ of the breast or atypical hyperplasia in the absence of DCIS are excluded
  • 4. Pathologist must be able to state that the excision margins are clear, even after re-excision
  • 5. No axillary lymph node involvement
  • 6. Able to receive either treatment

排除标准

  • 1. Involved excision margins
  • 2. Paget's Disease
  • 3. Nodal spread

研究者

发起方
Cancer Research UK (CRUK) (UK)

相似试验